Latest Urology News
New drugs routinely cost more than 100K per year; prices on many existing treatments continue to rise.
Patients who have a complete response to 2 or more years of anti-VEGF treatment have the best progression-free and overall survival.
Researchers calculated that the absolute increase in lifetime risk of prostate cancer associated with vasectomy was just 0.6%.
Study reveals that a quarter of men with low-volume intermediate-risk prostate cancer had adverse pathologic features found at radical prostatectomy.
Every additional 4 inches of height was associated with a 21% increase in risk of being diagnosed with high-grade prostate cancer, and a 17% increased risk of dying from prostate cancer.
Randomized trial found no significant difference in all-cause and cancer-specific survival between radical prostatectomy and observation for localized prostate cancer.
Across time, only African-American race correlated with greater regret.
In a study, a positive test result was associated with a 5-fold increased risk of recurrent non-muscle invasive bladder cancer.
The cap should not be used on children, patients with certain cancers, and those having specific kinds of chemotherapy.
A new review shows no significant differences in oncologic outcomes, long-term complications, and health-related quality of life between robot-assisted and open radical cystectomy.
The researchers found that postoperative delirium occurred in 24% of participants and that 12% had 2 or more delirium days.
Radiation dose area product fell from 318.4 to 6.4 cGy/cm2 over the study period.
Men with prostate cancer and at least one additional primary cancer are enriched for harboring a germline deleterious mutation in a cancer-predisposing gene.
Over a 10-year period, radical prostatectomy use increased steadily while radiotherapy use declined
Patients who underwent the minimally invasive procedure had a 36%, 50%, and 44% improvement in IPSS, quality of life, and peak flow rate, respectively, at 5 years.
Both findings on biopsy also predict a lower odds of high-grade cancer.
The researchers found that 57% of participants expressed interest in learning their secondary germline findings, while 29% and 14%, respectively, were equivocal or disinterested.
Symptomatic recurrence was associated with a nearly 2-fold higher risk of death from the time of recurrence versus surveillance-detected recurrence.
Hypogonadal testicular cancer survivors had 15 times higher odds of metabolic syndrome than their eugonadal counterparts.
Researchers saw a benefit in acupuncture for urinary incontinence, but did not see an impact for women with PCOS related infertiltiy.
Renal and Urology News Articles
- Active Surveillance for Intermediate-risk Prostate Cancer Challenged
- Ferritin Spike Soon After Hemodialysis Initiation Ups Mortality Risk
- Type of Long-term Response to Targeted mRCC Therapy Affects Outcomes
- Training Staff in HIPAA Regulations
- Hypothyroidism Tied to Worse Quality of Life for HD Patients
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)